Latest Articles
PRM Endometriosis Specialist Dr. Reza Askari Featured on - GlobeNewswire
PRM Endometriosis Specialist Dr. Reza Askari Featured on GlobeNewswire
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance Singapore
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance Singapore
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - finance.yahoo.com
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients finance.yahoo.com
Published: July 31, 2026, 3:47 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Proactive financial news
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Proactive financial news
Published: July 31, 2026, 3:20 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Yahoo Finance UK
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Yahoo Finance UK
Published: July 31, 2026, 3:09 p.m.
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged - TipRanks
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged TipRanks
Published: July 31, 2026, 2:09 p.m.
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis - Fierce Pharma
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis Fierce Pharma
Published: July 31, 2026, 2 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada
Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com
Published: July 31, 2026, 1:24 p.m.
Link copied to clipboard!